Saniona AB/Skr SANION
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Saniona AB
Saniona AB is a biopharmaceutical company based in Sweden, focusing on the discovery and development of treatments for rare diseases of the central nervous system. Its core business involves the research and development of ion channel modulators, which are pivotal in influencing cellular activity and treating neurological disorders. Saniona's pipeline includes product candidates such as Tesomet for rare eating disorders and SAN711 for neuropathic pain disorders. The company leverages its proprietary ion channel drug discovery platform to enhance its development capabilities. Saniona's strategic approach is distinguished by its focus on niche medical conditions with high unmet needs, positioning itself uniquely within the pharmaceutical industry. Sources: Saniona official website and public disclosures.
- Ticker
- Skr SANION
- Sector
- Health
- Primary listing
- XSTO
- Employees
- 44
- Headquarters
- Glostrup, Denmark
- Website
- saniona.com
Saniona AB Metrics
BasicAdvanced
kr 1.7B
9.26
kr 1.31
1.20
-
Price and volume
Market cap
kr 1.7B
Beta
1.2
52-week high
kr 28.30
52-week low
kr 8.53
Average daily volume
419K
Financial strength
Current ratio
9.646
Quick ratio
9.297
Interest coverage (TTM)
7.55%
Profitability
EBITDA (TTM)
203.605
Gross margin (TTM)
98.60%
Net profit margin (TTM)
43.23%
Operating margin (TTM)
47.14%
Effective tax rate (TTM)
8.84%
Revenue per employee (TTM)
kr 9,650,000
Management effectiveness
Return on assets (TTM)
24.46%
Return on equity (TTM)
40.58%
Valuation
Price to earnings (TTM)
9.258
Price to revenue (TTM)
3.896
Price to book
3.02
Price to tangible book (TTM)
3.04
Price to free cash flow (TTM)
8.623
Free cash flow yield (TTM)
11.60%
Free cash flow per share (TTM)
1.402
Growth
Revenue change (TTM)
24.98%
Earnings per share change (TTM)
-28.32%
3-year revenue growth (CAGR)
230.98%
10-year revenue growth (CAGR)
34.04%
3-year earnings per share growth (CAGR)
35.68%
10-year earnings per share growth (CAGR)
0.16%
Saniona AB Financial Performance
Revenues and expenses
Saniona AB Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.